Global Antibacterial Drugs Market Scrutinised in New Infiniti Research Report Now Available at MarketPublishers.com
24 Nov 2015 • by Natalie Aster
LONDON – Special regulatory destinations represent key force igniting growth of the global market for antibacterial drugs.
However, some forces pose a challenge to market growth, with patent expiries and genetic penetration as well as a decrease in investments in research activities being amongst major ones.
At present, the marketplace is characterized by a growing number of strategic alliances and M&A. Funding on antibiotic research also gains traction. Top vendors in this market comprise: Merck, Pfizer, Allergan, etc.
The global market is set to grow at a CAGR of slightly over 1 percent in the upcoming years.
New research study “Global Antibacterial Drugs Market 2015-2019” prepared by Infiniti Research offers a comprehensive guide to the global market for antibacterial drugs. The report provides an all-inclusive overview of the marketplace. It contains a detailed pipeline analysis and covers such products as Delafloxacin, Cadazolid, VivaGel, and more. The study investigates antimicrobial resistance and sheds light on the regulatory landscape. The research report explores market segments and performance of the marketplace across different regions. It concentrates on forces driving and restraining growth, looks at market trends and vendor landscape. The research study examines key vendors and contains future market outlook.
Global Antibacterial Drugs Market 2015-2019
Published: November, 2015
Price: US$ 3,000.00
More new in-demand reports by this renowned publisher are available at Infiniti Research page.